title: Comparative disposition of pharmacologic markers for cytochrome P-450 mediated metabolism, glomerular filtration rate, and extracellular and total body fluid volume of Greyhound and Beagle dogs.
abstract: The purpose of the study was to compare the disposition of pharmacologic markers for cytochrome P-450 (CYP) metabolism, glomerular filtration rate (GFR), and extracellular (ECFV) and total body fluid volumes (TBFV) of Greyhounds and Beagles. Six healthy Greyhound and six healthy Beagle dogs were studied. Antipyrine, a marker for CYP metabolism and TBFV, and inulin, a marker for the GFR and ECFV, were administered i.v. Samples were collected at predetermined times and plasma was analyzed by validated high-pressure liquid chromatography (HPLC) methods. There were no differences in the disposition or pharmacokinetic parameters for inulin between the dog breeds. However, the clearance of antipyrine (mean = 8.33 mL/min/kg) in Greyhounds was significantly slower than Beagles (13.42 mL/min/kg, P = 0.004). The volume of distribution of antipyrine was significantly larger in Greyhounds (0.789 L/kg) than in Beagles (0.644 L/kg, P = 0.01). The half-life of antipyrine was significantly longer in Greyhounds (1.09 h) compared with Beagles (0.55 h, P = 0.002). The in vitro plasma protein binding of antipyrine was significantly less in Greyhounds (28%) compared with Beagles (40.3%, P = 0.008). Greyhounds exhibited significantly slower CYP metabolism, higher TBFV, and lower in vitro protein binding of antipyrine compared with Beagles. No differences in GFR or ECFV were found.
authors.affiliation: Department of Anatomy, PharmCATS, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA. kukanich@ksu.edu
authors.forename: B
authors.initials: B
authors.lastname: KuKanich
authors.forename: J F
authors.initials: JF
authors.lastname: Coetzee
authors.forename: R
authors.initials: R
authors.lastname: Gehring
authors.forename: M
authors.initials: M
authors.lastname: Hubin
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D000983:Antipyrine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D019540:Area Under Curve; D015415:Biomarkers / Q000378:metabolism; D001834:Body Water / Q000502:physiology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004285:Dogs / Q000378:metabolism*; D005110:Extracellular Space / Q000502:physiology; D005260:Female; D005919:Glomerular Filtration Rate / Q000502:physiology / Q000662:veterinary; D007275:Injections, Intravenous / Q000662:veterinary; D007444:Inulin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D008297:Male; D010375:Pedigree
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D015415:Biomarkers; D007444:Inulin; D003577:Cytochrome P-450 Enzyme System; D000983:Antipyrine